nodes	percent_of_prediction	percent_of_DWPC	metapath
Trimethoprim—ABCB1—peripheral nervous system neoplasm	0.394	1	CbGaD
Trimethoprim—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0605	0.148	CbGbCtD
Trimethoprim—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.044	0.108	CbGbCtD
Trimethoprim—ABCB1—Topotecan—peripheral nervous system neoplasm	0.044	0.108	CbGbCtD
Trimethoprim—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0422	0.103	CbGbCtD
Trimethoprim—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0305	0.0745	CbGbCtD
Trimethoprim—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0264	0.0644	CbGbCtD
Trimethoprim—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0255	0.0621	CbGbCtD
Trimethoprim—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0245	0.0599	CbGbCtD
Trimethoprim—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0188	0.0459	CbGbCtD
Trimethoprim—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0181	0.0441	CbGbCtD
Trimethoprim—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0175	0.0428	CbGbCtD
Trimethoprim—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0172	0.0421	CbGbCtD
Trimethoprim—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0117	0.0287	CbGbCtD
Trimethoprim—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0113	0.0275	CbGbCtD
Trimethoprim—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0103	0.0252	CbGbCtD
Trimethoprim—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00704	0.0172	CbGbCtD
Trimethoprim—TYMS—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.000867	0.134	CbGdCrCtD
Trimethoprim—TYMS—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.000867	0.134	CbGdCrCtD
Trimethoprim—TYMS—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.000657	0.102	CbGdCrCtD
Trimethoprim—TYMS—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.000606	0.0937	CbGdCrCtD
Trimethoprim—TYMS—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000606	0.0937	CbGdCrCtD
Trimethoprim—TYMS—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.000606	0.0937	CbGdCrCtD
Trimethoprim—TYMS—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.000606	0.0937	CbGdCrCtD
Trimethoprim—TYMS—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000459	0.071	CbGdCrCtD
Trimethoprim—TYMS—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.000459	0.071	CbGdCrCtD
Trimethoprim—TYMS—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000272	0.0421	CbGdCrCtD
Trimethoprim—TYMS—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000272	0.0421	CbGdCrCtD
Trimethoprim—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000206	0.00109	CcSEcCtD
Trimethoprim—Dermatitis exfoliative—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.00108	CcSEcCtD
Trimethoprim—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000205	0.00108	CcSEcCtD
Trimethoprim—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000205	0.00108	CcSEcCtD
Trimethoprim—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000205	0.00108	CcSEcCtD
Trimethoprim—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000204	0.00108	CcSEcCtD
Trimethoprim—Renal impairment—Doxorubicin—peripheral nervous system neoplasm	0.000203	0.00107	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.00107	CcSEcCtD
Trimethoprim—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000202	0.00107	CcSEcCtD
Trimethoprim—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000202	0.00106	CcSEcCtD
Trimethoprim—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000201	0.00106	CcSEcCtD
Trimethoprim—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000201	0.00106	CcSEcCtD
Trimethoprim—Purpura—Doxorubicin—peripheral nervous system neoplasm	0.000201	0.00106	CcSEcCtD
Trimethoprim—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.0002	0.00106	CcSEcCtD
Trimethoprim—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.0002	0.00106	CcSEcCtD
Trimethoprim—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.0002	0.00105	CcSEcCtD
Trimethoprim—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000199	0.00105	CcSEcCtD
Trimethoprim—Hypoglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000198	0.00104	CcSEcCtD
Trimethoprim—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000197	0.00104	CcSEcCtD
Trimethoprim—Lethargy—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.00104	CcSEcCtD
Trimethoprim—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000197	0.00104	CcSEcCtD
Trimethoprim—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000197	0.00104	CcSEcCtD
Trimethoprim—Rash—Topotecan—peripheral nervous system neoplasm	0.000197	0.00104	CcSEcCtD
Trimethoprim—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000197	0.00104	CcSEcCtD
Trimethoprim—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.000197	0.00104	CcSEcCtD
Trimethoprim—Ataxia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00104	CcSEcCtD
Trimethoprim—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000196	0.00103	CcSEcCtD
Trimethoprim—Cough—Etoposide—peripheral nervous system neoplasm	0.000196	0.00103	CcSEcCtD
Trimethoprim—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000196	0.00103	CcSEcCtD
Trimethoprim—Headache—Topotecan—peripheral nervous system neoplasm	0.000196	0.00103	CcSEcCtD
Trimethoprim—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000195	0.00103	CcSEcCtD
Trimethoprim—Rash—Tretinoin—peripheral nervous system neoplasm	0.000195	0.00103	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000195	0.00103	CcSEcCtD
Trimethoprim—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000195	0.00103	CcSEcCtD
Trimethoprim—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000195	0.00103	CcSEcCtD
Trimethoprim—Convulsion—Etoposide—peripheral nervous system neoplasm	0.000195	0.00103	CcSEcCtD
Trimethoprim—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000195	0.00103	CcSEcCtD
Trimethoprim—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000194	0.00102	CcSEcCtD
Trimethoprim—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.000194	0.00102	CcSEcCtD
Trimethoprim—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000194	0.00102	CcSEcCtD
Trimethoprim—Headache—Tretinoin—peripheral nervous system neoplasm	0.000194	0.00102	CcSEcCtD
Trimethoprim—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000194	0.00102	CcSEcCtD
Trimethoprim—Constipation—Vincristine—peripheral nervous system neoplasm	0.000194	0.00102	CcSEcCtD
Trimethoprim—Rash—Melphalan—peripheral nervous system neoplasm	0.000193	0.00102	CcSEcCtD
Trimethoprim—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000193	0.00102	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00101	CcSEcCtD
Trimethoprim—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000191	0.00101	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.00019	0.001	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000188	0.000993	CcSEcCtD
Trimethoprim—TYMS—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000187	0.029	CbGdCrCtD
Trimethoprim—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000187	0.000984	CcSEcCtD
Trimethoprim—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000187	0.000984	CcSEcCtD
Trimethoprim—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000979	CcSEcCtD
Trimethoprim—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000186	0.000979	CcSEcCtD
Trimethoprim—Nausea—Topotecan—peripheral nervous system neoplasm	0.000186	0.000978	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000185	0.000976	CcSEcCtD
Trimethoprim—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000185	0.000974	CcSEcCtD
Trimethoprim—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000184	0.00097	CcSEcCtD
Trimethoprim—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000184	0.00097	CcSEcCtD
Trimethoprim—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000183	0.000966	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000182	0.000961	CcSEcCtD
Trimethoprim—Ataxia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000959	CcSEcCtD
Trimethoprim—Nausea—Melphalan—peripheral nervous system neoplasm	0.000182	0.000958	CcSEcCtD
Trimethoprim—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.00018	0.000946	CcSEcCtD
Trimethoprim—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000179	0.000943	CcSEcCtD
Trimethoprim—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000179	0.000943	CcSEcCtD
Trimethoprim—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000179	0.000943	CcSEcCtD
Trimethoprim—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000178	0.00094	CcSEcCtD
Trimethoprim—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000178	0.000939	CcSEcCtD
Trimethoprim—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000177	0.000934	CcSEcCtD
Trimethoprim—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000175	0.000921	CcSEcCtD
Trimethoprim—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000174	0.000918	CcSEcCtD
Trimethoprim—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000174	0.000917	CcSEcCtD
Trimethoprim—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000173	0.000914	CcSEcCtD
Trimethoprim—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000173	0.000912	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000173	0.000911	CcSEcCtD
Trimethoprim—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000172	0.000905	CcSEcCtD
Trimethoprim—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000169	0.000891	CcSEcCtD
Trimethoprim—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000167	0.000879	CcSEcCtD
Trimethoprim—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.000876	CcSEcCtD
Trimethoprim—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000873	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000165	0.00087	CcSEcCtD
Trimethoprim—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000165	0.000869	CcSEcCtD
Trimethoprim—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000864	CcSEcCtD
Trimethoprim—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000163	0.000862	CcSEcCtD
Trimethoprim—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000162	0.000854	CcSEcCtD
Trimethoprim—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000849	CcSEcCtD
Trimethoprim—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000849	CcSEcCtD
Trimethoprim—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000161	0.000849	CcSEcCtD
Trimethoprim—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000847	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.00016	0.000842	CcSEcCtD
Trimethoprim—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00016	0.000842	CcSEcCtD
Trimethoprim—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000159	0.00084	CcSEcCtD
Trimethoprim—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000159	0.000837	CcSEcCtD
Trimethoprim—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000835	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000158	0.000834	CcSEcCtD
Trimethoprim—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000158	0.000834	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000158	0.000833	CcSEcCtD
Trimethoprim—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000828	CcSEcCtD
Trimethoprim—Constipation—Etoposide—peripheral nervous system neoplasm	0.000157	0.000826	CcSEcCtD
Trimethoprim—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000156	0.000824	CcSEcCtD
Trimethoprim—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000155	0.000819	CcSEcCtD
Trimethoprim—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000155	0.000816	CcSEcCtD
Trimethoprim—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000154	0.00081	CcSEcCtD
Trimethoprim—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000153	0.000805	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000803	CcSEcCtD
Trimethoprim—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000801	CcSEcCtD
Trimethoprim—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000151	0.000796	CcSEcCtD
Trimethoprim—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00015	0.000793	CcSEcCtD
Trimethoprim—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000793	CcSEcCtD
Trimethoprim—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.00079	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00015	0.00079	CcSEcCtD
Trimethoprim—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00015	0.000789	CcSEcCtD
Trimethoprim—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000149	0.000787	CcSEcCtD
Trimethoprim—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000786	CcSEcCtD
Trimethoprim—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000786	CcSEcCtD
Trimethoprim—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.000781	CcSEcCtD
Trimethoprim—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000148	0.00078	CcSEcCtD
Trimethoprim—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000779	CcSEcCtD
Trimethoprim—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000147	0.000777	CcSEcCtD
Trimethoprim—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000147	0.000776	CcSEcCtD
Trimethoprim—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000773	CcSEcCtD
Trimethoprim—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.00077	CcSEcCtD
Trimethoprim—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000146	0.000768	CcSEcCtD
Trimethoprim—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000766	CcSEcCtD
Trimethoprim—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000145	0.000764	CcSEcCtD
Trimethoprim—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000145	0.000764	CcSEcCtD
Trimethoprim—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000144	0.000759	CcSEcCtD
Trimethoprim—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000143	0.000753	CcSEcCtD
Trimethoprim—Rash—Vincristine—peripheral nervous system neoplasm	0.000143	0.000752	CcSEcCtD
Trimethoprim—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000143	0.000752	CcSEcCtD
Trimethoprim—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000142	0.000749	CcSEcCtD
Trimethoprim—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000749	CcSEcCtD
Trimethoprim—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000142	0.000747	CcSEcCtD
Trimethoprim—Headache—Vincristine—peripheral nervous system neoplasm	0.000142	0.000747	CcSEcCtD
Trimethoprim—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000743	CcSEcCtD
Trimethoprim—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.000741	CcSEcCtD
Trimethoprim—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.000735	CcSEcCtD
Trimethoprim—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000733	CcSEcCtD
Trimethoprim—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000722	CcSEcCtD
Trimethoprim—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000137	0.000721	CcSEcCtD
Trimethoprim—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000713	CcSEcCtD
Trimethoprim—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000135	0.000712	CcSEcCtD
Trimethoprim—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000711	CcSEcCtD
Trimethoprim—Nausea—Vincristine—peripheral nervous system neoplasm	0.000134	0.000709	CcSEcCtD
Trimethoprim—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000697	CcSEcCtD
Trimethoprim—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000132	0.000693	CcSEcCtD
Trimethoprim—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000131	0.000692	CcSEcCtD
Trimethoprim—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000689	CcSEcCtD
Trimethoprim—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000687	CcSEcCtD
Trimethoprim—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00013	0.000684	CcSEcCtD
Trimethoprim—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000127	0.000671	CcSEcCtD
Trimethoprim—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000668	CcSEcCtD
Trimethoprim—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000667	CcSEcCtD
Trimethoprim—Rash—Cisplatin—peripheral nervous system neoplasm	0.000126	0.000665	CcSEcCtD
Trimethoprim—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000126	0.000664	CcSEcCtD
Trimethoprim—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000664	CcSEcCtD
Trimethoprim—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000664	CcSEcCtD
Trimethoprim—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000125	0.000661	CcSEcCtD
Trimethoprim—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000659	CcSEcCtD
Trimethoprim—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000658	CcSEcCtD
Trimethoprim—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000121	0.000639	CcSEcCtD
Trimethoprim—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000637	CcSEcCtD
Trimethoprim—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000636	CcSEcCtD
Trimethoprim—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000119	0.000627	CcSEcCtD
Trimethoprim—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000618	CcSEcCtD
Trimethoprim—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000117	0.000614	CcSEcCtD
Trimethoprim—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000614	CcSEcCtD
Trimethoprim—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000614	CcSEcCtD
Trimethoprim—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000116	0.00061	CcSEcCtD
Trimethoprim—Rash—Etoposide—peripheral nervous system neoplasm	0.000116	0.000609	CcSEcCtD
Trimethoprim—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000116	0.000609	CcSEcCtD
Trimethoprim—Headache—Etoposide—peripheral nervous system neoplasm	0.000115	0.000605	CcSEcCtD
Trimethoprim—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000596	CcSEcCtD
Trimethoprim—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000595	CcSEcCtD
Trimethoprim—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000594	CcSEcCtD
Trimethoprim—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000583	CcSEcCtD
Trimethoprim—Cough—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000579	CcSEcCtD
Trimethoprim—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000575	CcSEcCtD
Trimethoprim—Nausea—Etoposide—peripheral nervous system neoplasm	0.000109	0.000574	CcSEcCtD
Trimethoprim—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000565	CcSEcCtD
Trimethoprim—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000565	CcSEcCtD
Trimethoprim—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000564	CcSEcCtD
Trimethoprim—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000563	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000561	CcSEcCtD
Trimethoprim—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000552	CcSEcCtD
Trimethoprim—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000551	CcSEcCtD
Trimethoprim—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.00055	CcSEcCtD
Trimethoprim—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000546	CcSEcCtD
Trimethoprim—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000542	CcSEcCtD
Trimethoprim—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.00054	CcSEcCtD
Trimethoprim—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000536	CcSEcCtD
Trimethoprim—Shock—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000533	CcSEcCtD
Trimethoprim—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000532	CcSEcCtD
Trimethoprim—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000531	CcSEcCtD
Trimethoprim—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00053	CcSEcCtD
Trimethoprim—Skin disorder—Epirubicin—peripheral nervous system neoplasm	9.98e-05	0.000526	CcSEcCtD
Trimethoprim—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	9.92e-05	0.000523	CcSEcCtD
Trimethoprim—Myalgia—Doxorubicin—peripheral nervous system neoplasm	9.92e-05	0.000523	CcSEcCtD
Trimethoprim—Anxiety—Doxorubicin—peripheral nervous system neoplasm	9.89e-05	0.000521	CcSEcCtD
Trimethoprim—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	9.85e-05	0.000519	CcSEcCtD
Trimethoprim—Anorexia—Epirubicin—peripheral nervous system neoplasm	9.8e-05	0.000516	CcSEcCtD
Trimethoprim—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000505	CcSEcCtD
Trimethoprim—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000501	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	9.36e-05	0.000494	CcSEcCtD
Trimethoprim—Shock—Doxorubicin—peripheral nervous system neoplasm	9.36e-05	0.000493	CcSEcCtD
Trimethoprim—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.33e-05	0.000492	CcSEcCtD
Trimethoprim—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	9.31e-05	0.000491	CcSEcCtD
Trimethoprim—Insomnia—Epirubicin—peripheral nervous system neoplasm	9.3e-05	0.00049	CcSEcCtD
Trimethoprim—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.24e-05	0.000487	CcSEcCtD
Trimethoprim—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.16e-05	0.000483	CcSEcCtD
Trimethoprim—Anorexia—Doxorubicin—peripheral nervous system neoplasm	9.07e-05	0.000478	CcSEcCtD
Trimethoprim—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.05e-05	0.000477	CcSEcCtD
Trimethoprim—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	8.94e-05	0.000471	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	8.87e-05	0.000468	CcSEcCtD
Trimethoprim—Constipation—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000463	CcSEcCtD
Trimethoprim—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	8.66e-05	0.000457	CcSEcCtD
Trimethoprim—Insomnia—Doxorubicin—peripheral nervous system neoplasm	8.6e-05	0.000453	CcSEcCtD
Trimethoprim—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.000447	CcSEcCtD
Trimethoprim—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.47e-05	0.000446	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.41e-05	0.000443	CcSEcCtD
Trimethoprim—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.37e-05	0.000441	CcSEcCtD
Trimethoprim—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	8.27e-05	0.000436	CcSEcCtD
Trimethoprim—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000433	CcSEcCtD
Trimethoprim—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.00043	CcSEcCtD
Trimethoprim—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.13e-05	0.000429	CcSEcCtD
Trimethoprim—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000428	CcSEcCtD
Trimethoprim—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000428	CcSEcCtD
Trimethoprim—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	7.84e-05	0.000413	CcSEcCtD
Trimethoprim—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	7.78e-05	0.00041	CcSEcCtD
Trimethoprim—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.57e-05	0.000399	CcSEcCtD
Trimethoprim—Urticaria—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.000398	CcSEcCtD
Trimethoprim—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000396	CcSEcCtD
Trimethoprim—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000396	CcSEcCtD
Trimethoprim—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.27e-05	0.000383	CcSEcCtD
Trimethoprim—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000371	CcSEcCtD
Trimethoprim—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000369	CcSEcCtD
Trimethoprim—Dizziness—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000358	CcSEcCtD
Trimethoprim—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.73e-05	0.000355	CcSEcCtD
Trimethoprim—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.54e-05	0.000344	CcSEcCtD
Trimethoprim—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000343	CcSEcCtD
Trimethoprim—Rash—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000342	CcSEcCtD
Trimethoprim—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.47e-05	0.000341	CcSEcCtD
Trimethoprim—Headache—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.000339	CcSEcCtD
Trimethoprim—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000331	CcSEcCtD
Trimethoprim—Nausea—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000322	CcSEcCtD
Trimethoprim—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.05e-05	0.000319	CcSEcCtD
Trimethoprim—Rash—Doxorubicin—peripheral nervous system neoplasm	6e-05	0.000316	CcSEcCtD
Trimethoprim—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000316	CcSEcCtD
Trimethoprim—Headache—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000314	CcSEcCtD
Trimethoprim—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.000298	CcSEcCtD
